# OnCo record stephen-boorjian (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/stephen-boorjian/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "stephen-boorjian" ;
  schema:name "Stephen A. Boorjian"@en ;
  schema:description "Mayo Clinic urologist who led the trial of nadofaragene firadenovec, the first gene therapy approved for bladder cancer that no longer responds to BCG."@en ;
  schema:url <https://onco.cc/people/stephen-boorjian/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "urothelial", "gene-therapy", "surgery", "trialist" ;
  schema:jobTitle "Chair of Urology, Mayo Clinic" ;
  onco:cancers <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/>, <https://onco.cc/cancers/urothelial/> ;
  onco:institutions <https://onco.cc/institutions/mayo-clinic/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nadofaragene-firadenovec-lancet-oncol-2021/> ;
  schema:affiliation <https://onco.cc/institutions/mayo-clinic/> .